<?xml version='1.0' encoding='utf-8'?>
<document id="24962473"><sentence text="Investigation of mutual pharmacokinetic interactions between macitentan, a novel endothelin receptor antagonist, and sildenafil in healthy subjects."><entity charOffset="61-71" id="DDI-PubMed.24962473.s1.e0" text="macitentan" /><entity charOffset="117-127" id="DDI-PubMed.24962473.s1.e1" text="sildenafil" /><pair ddi="false" e1="DDI-PubMed.24962473.s1.e0" e2="DDI-PubMed.24962473.s1.e0" /><pair ddi="false" e1="DDI-PubMed.24962473.s1.e0" e2="DDI-PubMed.24962473.s1.e1" /></sentence><sentence text="To study the mutual pharmacokinetic interactions between macitentan, an endothelin receptor antagonist, and sildenafil in healthy male subjects"><entity charOffset="57-67" id="DDI-PubMed.24962473.s2.e0" text="macitentan" /><entity charOffset="108-118" id="DDI-PubMed.24962473.s2.e1" text="sildenafil" /><pair ddi="false" e1="DDI-PubMed.24962473.s2.e0" e2="DDI-PubMed.24962473.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24962473.s2.e0" e2="DDI-PubMed.24962473.s2.e1" /></sentence><sentence text="" /><sentence text="In this open-label, randomized, three way crossover study, 12 healthy male subjects received the following oral treatments: A) a loading dose of 30 mg macitentan on day 1 followed by 10 mg once daily for 3 days, B) sildenafil 20 mg three times a day for 3 days and a single 20 mg dose on day 4 and C) both treatments A and B concomitantly"><entity charOffset="151-161" id="DDI-PubMed.24962473.s4.e0" text="macitentan" /><entity charOffset="215-225" id="DDI-PubMed.24962473.s4.e1" text="sildenafil" /><pair ddi="false" e1="DDI-PubMed.24962473.s4.e0" e2="DDI-PubMed.24962473.s4.e0" /><pair ddi="false" e1="DDI-PubMed.24962473.s4.e0" e2="DDI-PubMed.24962473.s4.e1" /></sentence><sentence text=" Plasma concentration-time profiles of macitentan and its active metabolite ACT-132577 (treatments A and C) and sildenafil and its N-desmethyl metabolite (treatments B and C) were determined on day 4 and analyzed non-compartmentally"><entity charOffset="39-49" id="DDI-PubMed.24962473.s5.e0" text="macitentan" /><entity charOffset="76-86" id="DDI-PubMed.24962473.s5.e1" text="ACT-132577" /><entity charOffset="112-122" id="DDI-PubMed.24962473.s5.e2" text="sildenafil" /><entity charOffset="131-142" id="DDI-PubMed.24962473.s5.e3" text="N-desmethyl" /><pair ddi="false" e1="DDI-PubMed.24962473.s5.e0" e2="DDI-PubMed.24962473.s5.e0" /><pair ddi="false" e1="DDI-PubMed.24962473.s5.e0" e2="DDI-PubMed.24962473.s5.e1" /><pair ddi="false" e1="DDI-PubMed.24962473.s5.e0" e2="DDI-PubMed.24962473.s5.e2" /><pair ddi="false" e1="DDI-PubMed.24962473.s5.e0" e2="DDI-PubMed.24962473.s5.e3" /><pair ddi="false" e1="DDI-PubMed.24962473.s5.e1" e2="DDI-PubMed.24962473.s5.e1" /><pair ddi="false" e1="DDI-PubMed.24962473.s5.e1" e2="DDI-PubMed.24962473.s5.e2" /><pair ddi="false" e1="DDI-PubMed.24962473.s5.e1" e2="DDI-PubMed.24962473.s5.e3" /><pair ddi="false" e1="DDI-PubMed.24962473.s5.e2" e2="DDI-PubMed.24962473.s5.e2" /><pair ddi="false" e1="DDI-PubMed.24962473.s5.e2" e2="DDI-PubMed.24962473.s5.e3" /></sentence><sentence text="" /><sentence text="The pharmacokinetics of macitentan were not affected by sildenafil"><entity charOffset="24-34" id="DDI-PubMed.24962473.s7.e0" text="macitentan" /><entity charOffset="56-66" id="DDI-PubMed.24962473.s7.e1" text="sildenafil" /><pair ddi="false" e1="DDI-PubMed.24962473.s7.e0" e2="DDI-PubMed.24962473.s7.e0" /><pair ddi="false" e1="DDI-PubMed.24962473.s7.e0" e2="DDI-PubMed.24962473.s7.e1" /></sentence><sentence text=" In the presence of sildenafil Cmax and AUCτ of the metabolite ACT-132577 decreased with geometric mean ratios (90% confidence interval (CI)) of 0"><entity charOffset="20-30" id="DDI-PubMed.24962473.s8.e0" text="sildenafil" /><entity charOffset="63-73" id="DDI-PubMed.24962473.s8.e1" text="ACT-132577" /><pair ddi="false" e1="DDI-PubMed.24962473.s8.e0" e2="DDI-PubMed.24962473.s8.e0" /><pair ddi="false" e1="DDI-PubMed.24962473.s8.e0" e2="DDI-PubMed.24962473.s8.e1" /></sentence><sentence text="82 (0" /><sentence text="76, 0" /><sentence text="89) and 0" /><sentence text="85 (90% CI 0" /><sentence text="80, 0" /><sentence text="91), respectively" /><sentence text=" In the presence of macitentan, plasma concentrations of sildenafil were higher than during treatment with sildenafil alone, resulting in increased Cmax and AUCτ values"><entity charOffset="20-30" id="DDI-PubMed.24962473.s15.e0" text="macitentan" /><entity charOffset="57-67" id="DDI-PubMed.24962473.s15.e1" text="sildenafil" /><entity charOffset="107-117" id="DDI-PubMed.24962473.s15.e2" text="sildenafil" /><pair ddi="false" e1="DDI-PubMed.24962473.s15.e0" e2="DDI-PubMed.24962473.s15.e0" /><pair ddi="false" e1="DDI-PubMed.24962473.s15.e0" e2="DDI-PubMed.24962473.s15.e1" /><pair ddi="false" e1="DDI-PubMed.24962473.s15.e0" e2="DDI-PubMed.24962473.s15.e2" /><pair ddi="false" e1="DDI-PubMed.24962473.s15.e1" e2="DDI-PubMed.24962473.s15.e1" /><pair ddi="false" e1="DDI-PubMed.24962473.s15.e1" e2="DDI-PubMed.24962473.s15.e2" /></sentence><sentence text=" The respective geometric mean ratios were 1" /><sentence text="26 (90% CI 1" /><sentence text="07, 1" /><sentence text="48) and 1" /><sentence text="15 (90% CI 0" /><sentence text="94, 1" /><sentence text="41)" /><sentence text=" The pharmacokinetics of N-desmethylsildenafil were not affected by macitentan"><entity charOffset="25-46" id="DDI-PubMed.24962473.s23.e0" text="N-desmethylsildenafil" /><entity charOffset="68-78" id="DDI-PubMed.24962473.s23.e1" text="macitentan" /><pair ddi="false" e1="DDI-PubMed.24962473.s23.e0" e2="DDI-PubMed.24962473.s23.e0" /><pair ddi="false" e1="DDI-PubMed.24962473.s23.e0" e2="DDI-PubMed.24962473.s23.e1" /></sentence><sentence text=" All treatments were well tolerated" /><sentence text="" /><sentence text="A minor, not clinically relevant, pharmacokinetic interaction was observed between macitentan and sildenafil"><entity charOffset="83-93" id="DDI-PubMed.24962473.s26.e0" text="macitentan" /><entity charOffset="98-108" id="DDI-PubMed.24962473.s26.e1" text="sildenafil" /><pair ddi="false" e1="DDI-PubMed.24962473.s26.e0" e2="DDI-PubMed.24962473.s26.e0" /><pair ddi="false" e1="DDI-PubMed.24962473.s26.e0" e2="DDI-PubMed.24962473.s26.e1" /></sentence><sentence text=" Based on these results, no dose adjustment of either compound appears necessary during concomitant treatment with macitentan and sildenafil"><entity charOffset="115-125" id="DDI-PubMed.24962473.s27.e0" text="macitentan" /><entity charOffset="130-140" id="DDI-PubMed.24962473.s27.e1" text="sildenafil" /><pair ddi="false" e1="DDI-PubMed.24962473.s27.e0" e2="DDI-PubMed.24962473.s27.e0" /><pair ddi="false" e1="DDI-PubMed.24962473.s27.e0" e2="DDI-PubMed.24962473.s27.e1" /></sentence><sentence text="" /></document>